Login / Signup

Is a BTKi or BCL2i preferable for first "novel" therapy in CLL? The case for BTKis.

Elizabeth A BremSusan O'Brien
Published in: Blood advances (2022)
Keyphrases
  • chronic lymphocytic leukemia
  • smoking cessation
  • replacement therapy